According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 2.5% and a 50.68% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as Telix Pharmaceuticals, ...

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on ...

Amendment reduces and simplifies royalty structure on Teverelix® from ~4% to 2% while preserving global rights and IP control ...

The business remains strong, contracts keep flowing, and yet the share price is far lower than it was a year ago. The post ...

USA-based Medicus Pharma’ Antev subsidiary has agreed to amend its licensing deal with UK-based medical research organization LifeArc relating to teverelix, an investigational next generation ...

Analysts think these top stocks are great options for Aussie investors. Let's see what makes them stand out. The post Top ...

Reimbursement issues, staffing shortages and rising costs are just a few of the challenges facing ASC leadership teams in 2026. Here are 20 statistics demonstrating the scale and scope of the ASC ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing ...

Find insight on Roche Holdings, U.S. healthcare stocks and more in the latest Market Talks covering the health care sector.

Midtown virtual care startup Salvo Health raised $8.5 million to fund a hiring spree of dieticians, nurses and behavioral health providers, as it scales up treatment of patients with gastrointestinal ...

Leaders from medical marketing shops like AbelsonTaylor Group, Merge and Citrus Health weigh in on Omnicom’s impact on the Chicago ad scene.

These shares are starting the week with a bang. But why? The post Why Dateline, EOS, Karoon Energy, and Pro Medicus shares are charging higher today appeared first on The Motley Fool Australia.